It has been reported that KRAS mutations occur in approximately 27% to 43% of CRC patients, with common mutation hotspots located in codons 12 and 13 of exon 2, including notable mutations of G13D, G12D, G12A, G12V, G12S, G12R, and G12C [10,11]. Here, KRAS is linked to colorectal carcinoma.